Journal Article

Urolithiasis in HIV-Positive Patients Treated with Atazanavir

Carine Couzigou, Michel Daudon, Jean Luc Meynard, Françoise Borsa Lebas, Denise Higueret, Lélia Escaut, David Zucman, Jean-Yves Liotier, Jean-Louis Quencez, Karine Asselah, Thierry May, Didier Neau and Daniel Vittecoq

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 45, issue 8, pages e105-e108
Published in print October 2007 | ISSN: 1058-4838
Published online October 2007 | e-ISSN: 1537-6591 | DOI: http://dx.doi.org/10.1086/521930
Urolithiasis in HIV-Positive Patients Treated with Atazanavir

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

Among protease inhibitors, atazanavir has not been associated with urolithiasis in clinical studies. We describe 11 cases of atazanavir-associated urolithiasis in patients with human immunodeficiency virus (HIV) infection. Patients with low water intake, high urinary pH, and a prior history of urinary stones may have a higher risk of atazanavir-associated urine crystallization.

Journal Article.  1601 words.  Illustrated.

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.